IthaID: 3551


Names and Sequences

Functionality: Disease modifying mutation Pathogenicity: N/A
Common Name: FCGR2C.nc-ORF HGVS Name: NG_011982.1:g.[13259C>T;19253A>G]

Also known as:

Comments: The FCGR2C.nc-ORF variant is a combination of an exon 3 SNP (rs759550223) and a splice site mutation near exon 7 (rs76277413). It was strongly associated with a decreased red blood cell allo-immunization risk among patients with sickle cell disease acquired from the Dutch STAR and the French SCDTRANSFU cohorts. This protective effect was strongest for exposure to antigens other than the immunogenic Rh or K antigens.

We follow the HGVS sequence variant nomenclature and IUPAC standards.

External Links

Phenotype

Allele Phenotype (Cis):N/A
Allele Phenotype (Trans):N/A
Associated Phenotypes: Red blood cell alloimmunisation

Location

Chromosome: 1
Locus: NG_011982.1
Locus Location: 13259 or 19253
Size: 1 bp or 1 bp
Located at: FCGR2C
Specific Location: Exon 3

Other details

Type of Mutation: Point-Mutation(Substitution)
Effect on Gene/Protein Function: N/A
Ethnic Origin: African, Latin-American
Molecular mechanism: N/A
Inheritance: Quantitative trait
DNA Sequence Determined: Yes

In silico pathogenicity prediction

Publications / Origin

  1. Meinderts SM, Sins JWR, Fijnvandraat K, Nagelkerke SQ, Geissler J, Tanck MW, Bruggeman C, Biemond BJ, Rijneveld AW, Kerkhoffs JH, Pakdaman S, Habibi A, van Bruggen R, Kuijpers TW, Pirenne F, van den Berg TK, Non-classical FCGR2C haplotype is associated with protection from red blood cell allo-immunization in sickle cell disease., Blood , 2017
Created on 2019-12-20 14:14:31, Last reviewed on 2019-12-21 10:39:39 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.